Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-Arrhythmic Medication v. MRI-Merge Ablation in the Treatment of Ventricular Tachycardia
This study is not yet open for participant recruitment.
Study NCT00721032   Information provided by Johns Hopkins University
First Received: July 21, 2008   Last Updated: July 23, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Ventricular Tachycardia
Additional conditions recognized in this trial
Tachycardia
Tachycardia, Ventricular
More general conditions related to this trial
Arrhythmias, Cardiac
Cardiovascular Diseases
Heart Diseases
Pathologic Processes
Interventions listed in this trial
MRI guided VT ablation
Increased dose of amiodarone
Additional drug interventions recognized in this trial
Amiodarone
Anti-Arrhythmia Agents
More general drug interventions related to this trial
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Johns Hopkins University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services